Page last updated: 2024-08-23

piritrexim and Lung Neoplasms

piritrexim has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baccanari, DP; Boytos, CM; Caddell, JM; Comley, JC; Friedman, HS; Hunter, RN; Jones, ML; Joyner, SS; Knick, V; Kuyper, LF; Rudolph, SK; Stables, JN; Tansik, RL; Wilson, HR	1
de Wit, R; Slingerland, R; Stoter, G; Verweij, J	1
Clendeninn, NJ; Feun, LG; Gonzalez, R; Liebmann, A; Offenhauser, K; Robinson, WA; Savaraj, N	1

Trials

2 trial(s) available for piritrexim and Lung Neoplasms

Article	Year
Piritrexim-induced pulmonary toxicity. American journal of clinical oncology, 1993, Volume: 16, Issue:2 Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Pulmonary Fibrosis; Pyrimidines	1993
Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma. American journal of clinical oncology, 1995, Volume: 18, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Pyrimidines; Remission Induction	1995

Article

Year

Piritrexim-induced pulmonary toxicity.

American journal of clinical oncology, 1993, Volume: 16, Issue:2

Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Pulmonary Fibrosis; Pyrimidines

1993

Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma.

American journal of clinical oncology, 1995, Volume: 18, Issue:6

Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Pyrimidines; Remission Induction

1995

Other Studies

1 other study(ies) available for piritrexim and Lung Neoplasms

Article	Year
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. Journal of medicinal chemistry, 1996, Feb-16, Volume: 39, Issue:4 Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Candidiasis; Cell Division; Cell Line; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Nude; Mice, SCID; Models, Molecular; Molecular Conformation; Molecular Structure; Molecular Weight; Pneumonia, Pneumocystis; Protein Structure, Secondary; Quinazolines; Structure-Activity Relationship; Toxoplasma; Tumor Cells, Cultured	1996

Article

Year

High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.

Journal of medicinal chemistry, 1996, Feb-16, Volume: 39, Issue:4

Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Candidiasis; Cell Division; Cell Line; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Nude; Mice, SCID; Models, Molecular; Molecular Conformation; Molecular Structure; Molecular Weight; Pneumonia, Pneumocystis; Protein Structure, Secondary; Quinazolines; Structure-Activity Relationship; Toxoplasma; Tumor Cells, Cultured

1996